RESUMO
BACKGROUND: The abdominal wall may be severely compromised in the vast majority of intestinal and multiorgan transplant candidates, and sometimes as a consequence of complex liver transplantation. Multiple options have been described to overcome this problem, varying from component separation to the extreme need of performing an abdominal wall transplantation. The aim of the present paper is to report the largest and longest-term results of patients that received an abdominal rectus fascia (ARF) after liver, intestinal, or multiorgan transplantation at a single transplant center. METHODS: This is a retrospective report of a prospectively collected dataset of all the patients that received ARF during liver, isolated intestine, combined, or multiorgan transplantation at Fundación Favaloro from May 2006 to June 2016. RESULTS: A total of 19 out of 528 patients (3.5%) that underwent abdominal organ transplant received an ARF graft: 17 patients after receiving an intestine-containing graft, and 2 after liver retransplantations. Three patients required changing the ARF, 2 with a synthetic mesh and 1 with another ARF. Five patients required late reoperations: A relaparotomy was performed by transecting the ARF without encountering adhesions on the inner ARF surface. None of the 2 patients who received liver retransplantations and ARF developed acute or chronic ventral defects. CONCLUSIONS: The use of ARF is a simple and reliable surgical option to close abdominal wall defects during transplantation, the fascia adequately incorporates to the abdominal wall, allowing it to be transected and resutured in the long term and preserving the integrity of the peritoneal layer.
Assuntos
Técnicas de Fechamento de Ferimentos Abdominais , Fáscia/transplante , Intestino Delgado/transplante , Transplante de Fígado , Reto do Abdome/transplante , Adulto , Criança , Seguimentos , Humanos , Estudos Retrospectivos , Resultado do TratamentoRESUMO
BACKGROUND: Intestinal failure (IF) patients received parenteral nutrition (PN) as the only available therapy until intestinal transplantation (ITx) evolved as an accepted treatment. The aim of this article is to report the long-term outcomes of a series of ITx performed in pediatric and adult patients at a single center 9 years after its creation. PATIENTS AND METHODS: This is a retrospective analysis of the ITx performed between May 2006 and January 2015. Diagnoses, pre-ITx mean time on PN, indications for ITx, time on the waiting list for types of ITx, mean total ischemia time, and warm ischemia time, time until PN discontinuation, incidence of acute and chronic rejection, and 5-year actuarial patient survival are reported. RESULTS: A total of 42 patients received ITx; 80% had short gut syndrome (SG); the mean time on PN was 1620 days. The main indication for ITx was lack of central venous access followed by intestinal failure-associated liver disease (IFALD) and catheter-related infectious complications. The mean time on the waiting list was 188 days (standard deviation, ±183 days). ITx were performed in 26 children and 14 adults. In all, 32 procedures were isolated ITx (IITX); 10 were multiorgan Tx (MOT; 3 combined, 7 multivisceral Tx (MVTx), 1 modified MVTx and 2 with kidney); 2 (4.7 %) were retransplantations: 1 IITx, 1 MVTx, and 5 including the right colon. Thirteen patients (31%) received abdominal rectus fascia. All procedures were performed by the same surgical team. Total ischemia time was 7:53 ± 2:04 hours, and warm ischemia time was 40.2 ± 10.5 minutes. The mean length of implanted intestine was 325 ± 63 cm. Bishop-Koop ileostomy was performed in 67% of cases. In all, 16 of 42 Tx required early reoperations. The overall mean follow-up time was 41 ± 35.6 months. The mean time to PN discontinuation after Tx was 68 days (P = .001). The total number of acute cellular rejection (ACR) episodes until the last follow-up was 83; the total number of grafts lost due to ACR was 4; and the total graft lost due to chronic rejection was 3. At the time of writing, the overall 5-year patient survival is 55% (65% for IITx vs 22% for MOT; P = .0001); 60% for pediatric recipients vs 47% for adults (P = NS); 64% when the indication for ITx was SG vs 25% for non-SG (P = .002). CONCLUSIONS: At this center, candidates with SG, in the absence of IFALD requiring IITx, showed the best long-term outcomes, independent of recipient age. A multidisciplinary approach is mandatory for the care of intestinal failure patients, to sustain a rehabilitation and transplantation program over time.
Assuntos
Rejeição de Enxerto/epidemiologia , Intestinos/transplante , Falência Renal Crônica/cirurgia , Falência Hepática/cirurgia , Transplante de Fígado , Nutrição Parenteral Total/estatística & dados numéricos , Complicações Pós-Operatórias/epidemiologia , Síndrome do Intestino Curto/cirurgia , Adulto , Argentina , Criança , Feminino , Humanos , Enteropatias/complicações , Enteropatias/cirurgia , Falência Renal Crônica/complicações , Falência Hepática/etiologia , Masculino , Nutrição Parenteral Total/efeitos adversos , Reoperação , Estudos Retrospectivos , Síndrome do Intestino Curto/complicações , Listas de Espera , Isquemia QuenteRESUMO
Normal small bowel length (SBL) has been reported within a wide range, but never studied in a cohort of either pediatric or adult deceased donors. Between 5/2006 and 2/2011, SBL was measured in all grafts procured for intestinal transplantation at a single center and used for either isolated intestinal transplant (15) or multiorgan transplants (5) employing a standardized method. SBL was the only not significantly different variable among pediatric and adult donors divided by age 16. Furthermore, donors were classified in 3 groups: group 1: Height < 70 cm, group 2: 71-150 cm and group 3: ≥ 151 cm. Mean age was: 0.58, 5.6, 22.01 years, respectively. Mean height and weight were 65.8, 123.2, 166.1 cm (p = 0.001) and 6.9, 23.8, 65.2 kg (p = 0.001), for each group. The SBL by group was: 283.0, 324.7, 356.0 cm, remaining as the only nonsignificant variable (p = 0.06), in contrast to BMI, BSA (p = 0.001). The SBL/height ratio: 4.24, 2.7, 2.12 (p = 0.001; rho: -0.623) or SBL/BSA ratio was 8.36, 3.7, and 2.03, respectively (p : 0.0001; rho: -0.9). SBL does not increase with growth like other anthropometric variables. The SBL/height ratio significantly decreases with growth; however, bowel diameter increases, which needs further evaluation.
Assuntos
Intestino Delgado/anatomia & histologia , Intestino Delgado/transplante , Transplante de Órgãos , Doadores de Tecidos , Adolescente , Adulto , Estatura , Índice de Massa Corporal , Peso Corporal , Criança , Pré-Escolar , Estudos de Coortes , Feminino , Humanos , Lactente , Masculino , Estudos Retrospectivos , Adulto JovemRESUMO
El cáncer pulmonar es el más mortal de todos los cánceres. Debido a que la gran mayoría de los cánceres pulmonares son causados por el hábito de fumar, su erradicación es la mejor estrategia de prevención primaria. El diagnóstico del cáncer pulmonar en etapas tempranas mejora significativamente su pronóstico, por lo que ésta es la mejor estrategia de prevención secundaria. Recientemente se ha reportado que un programa de pesquisa de cáncer pulmonar con escáner de tórax (TAC) reduce la mortalidad por cáncer. El objetivo de esta revisión es, en primer lugar, apelar a la evidencia en cuanto al rendimiento de los programas de pesquisa de cáncer pulmonar en poblaciones de alto riesgo, y en segundo lugar, analizar las distintas estrategias que tiene un médico cuando se enfrenta a un paciente a quien se le ha encontrado incidentalmente un nódulo pulmonar.
Lung cancer is a deadly disease. Since this cancer is closely related to tobacco smoke, the best way to avoid this disease is smoking prevention. Unfortunately smoking is a worldwide epidemic and in Chile its prevalence is not decreasing. The second best strategy is an early detection. For the first time there is a report showing that screening with the use of low dose CT reduces mortality from lung cancer. The prognosis is much better in early stages. The purpose of this publication is to review the evidence about screening of lung cancer, and to analyze the different strategies to deal, in the general practice, with a finding of a lung nodule.
Assuntos
Humanos , Prevenção de Doenças , Diagnóstico Precoce , Neoplasias Pulmonares/diagnóstico , Neoplasias Pulmonares/prevenção & controle , Prevenção Secundária , Nódulos Pulmonares Múltiplos , Tomografia Computadorizada por Raios X , Tabagismo/efeitos adversosAssuntos
Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Gravidez , Adulto Jovem , Vírus da Influenza A Subtipo H1N1 , Influenza Humana/virologia , Fatores Etários , Chile/epidemiologia , Hospitalização/estatística & dados numéricos , Influenza Humana/diagnóstico , Influenza Humana/epidemiologia , Índice de Gravidade de Doença , Adulto JovemRESUMO
INTRODUCTION: The new pandemic influenza A H1N1 2009 virus has shown a different clinical behavior in different age groups. OBJECTIVE: To describe the clinical features of adult patients hospitalized with influenza AH1N1 2009 and compare the clinical and demographic variables among adults < 50 years and over 50 years old. PATIENTS AND METHOD: We included hospitalized patients between May 17 and July 17, 2009 confirmed by polymerase chain reaction (PCR) and/or rapid test for influenza A. RESULTS: 124 patients were hospitalized with a median age of 33 years (range: 15-82 years). 36% had comorbidities and the main symptoms were fever, cough, myalgia and sore throat. There were 16 cases with pneumonia. From 124 patients, 77% were < 50 and 23% > or = 50, [corrected] with comorbidity of 21% and 86%, respectively. There were no fatalities. CONCLUSIONS: Hospitalized patients had mild to moderate disease, a benign course and short hospitalization stay. There were more hospitalizations in A-49 and higher comorbidity in A-50.
Assuntos
Vírus da Influenza A Subtipo H1N1 , Influenza Humana/virologia , Adolescente , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Chile/epidemiologia , Feminino , Hospitalização/estatística & dados numéricos , Humanos , Influenza Humana/diagnóstico , Influenza Humana/epidemiologia , Masculino , Pessoa de Meia-Idade , Gravidez , Índice de Gravidade de Doença , Adulto JovemRESUMO
Introduction: The new pandemic influenza A H1N1 2009 virus has shown a different clinical behavior in different age groups. Objective: To describe the clinical features of adult patients hospitalized with influenza AH1N1 2009 and compare the clinical and demographic variables among adults < 50 years and over 50 years old. Patients and Method: We included hospitalized patients between May 17 and July 17, 2009 confirmed by polymerase chain reaction (PCR) and/or rapid test for influenza A. Results: 124 patients were hospitalized with a median age of 33 years (range: 15-82 years). 36 percent had comorbidities and the main symptoms were fever, cough, myalgia and sore throat. There were 16 cases with pneumonia. From 124 patients, 77 percent were A-49 and 23 percentA-50, with comorbidity of 21 percent and 86 percent, respectively. There were no fatalities. Conclusions: Hospitalized patients had mild to moderate disease, a benign course and short hospitalization stay. There were more hospitalizations in A-49 and higher comorbidity in A-50.
Introducción: El nuevo virus influenza AH1N1 2009 ha mostrado un comportamiento clínico diferente en distintos grupos etáreos. Objetivo: Describir las características clínicas de los pacientes adultos hospitalizados con influenza A H1N1 2009 y comparar las variables clínicas y demográficas entre menores y mayores de 50 años. Pacientes y Método: Se incluyeron los pacientes hospitalizados entre el 17 de mayo y 17 de julio del 2009 confirmados por reacción de polimerasa en cadena (RPC) y/o pruebas rápidas para influenza A. Resultados: Se hospitalizaron 124 pacientes con una mediana de edad de 33 años (rango: 15-82 años). Un 36 por ciento presentó co-morbilidad y los síntomas principales fueron: fiebre, tos, mialgias y odinofagia. Hubo 16 casos con neumonía. Del total, 77 por ciento fueron < 50 y 23 por ciento ≥ 50 años. Tenían co-morbilidades 21 por ciento en el grupo < 50 versus 86 por ciento en ≥ 50 años. No hubo casos fatales. Conclusiones: Los pacientes presentaron una enfermedad leve a moderada, de curso benigno y corta hospitalización. Hubo más hospitalizados en < 50 y mayor co-morbilidad en ≥ 50 años.
Assuntos
Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Gravidez , Adulto Jovem , Vírus da Influenza A Subtipo H1N1 , Influenza Humana/virologia , Fatores Etários , Chile/epidemiologia , Hospitalização/estatística & dados numéricos , Influenza Humana/diagnóstico , Influenza Humana/epidemiologia , Índice de Gravidade de Doença , Adulto JovemRESUMO
Background: The epidemic of cardiovascular diseases in Chile, requires the development of strategies in health promotion and prevention. Aim: To assess the prevalence of risk factors for chronic non communicable diseases among workers of a financial company in Metropolitan Santiago. Material and Methods: Assessment of 2,225 workers (1,383 males with a median age of 49 years and 842 females with a median age of 43 years). All answered an enquiry about education, medical history, smoking habits and physical activity. Body mass index and blood pressure were measured and a blood sample was obtained to measure blood glucose and lipid levels. Logistic repression models were used to determine the main risk factors for hypertension, diabetes, obesity, hypercholesterolemia and hyperuricemia. Results: Sixteen percent of studied subjects were obese, 49% had overweight, 57% had hypercholesterolemia, 28% had high blood pressure, 4% were diabetic, 4% had hyperuricemia, 45% smoked and 83% were sedentary. Each worker had a mean of 2.4±1.1 risk factors. This figure was significantly higher among men, obese subjects, those older than 40 years and those with a lower educational level. Conclusions: There is an important disease burden among the studied subjects, specially among obese and older individuals. Healthy lifestyles should be promoted in this population.
Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Doença Crônica/epidemiologia , Chile/epidemiologia , Métodos EpidemiológicosRESUMO
BACKGROUND: Our laboratory has carried out an epidemiological surveillance of Helicobacter pylori antimicrobial susceptibility since 1997. AIM: To report the antimicrobial susceptibility of H pylori strains, isolated in Chile from August 1997 to August 2000. MATERIAL AND METHODS: Ninety one H pylori strains, obtained from antral gastric biopsies during upper gastrointestinal endoscopies were studied. Susceptibility towards clarithromycin, amoxicillin, bismuth subcitrate and metronidazole was studied by an agar diffusion technique. RESULTS: All strains were susceptible to amoxicillin and two strains were resistant to clarithromycin. Forty two percent of strains were resistant to metronidazole and 13% were resistant to bismuth subcitrate. CONCLUSIONS: These results underscore the need to maintain an epidemiological surveillance of H pylori antimicrobial susceptibility, to modify its eradication therapy accordingly.